Functional and molecular characterization of the effect of amyloid-β42 on an in vitro epithelial barrier model

Journal of Alzheimer's Disease

Volumn 38, Issue 4, 2014, Pages 787-798

  Gheorghiu, Mihaela ^a   Enciu, Ana Maria ^b,c   Popescu, Bogdan O ^b,c   Gheorghiu, Eugen ^a  

^a International Centre of Biodynamics Bucharest   (Romania)

^b VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Alzheimer's disease; Amyloid ; Blood brain barrier; Claudin 2; Endothelial cells; Occluding; Permeability

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CLAUDIN 2; OCCLUDIN;

ALZHEIMER DISEASE; ARTICLE; ATOMIC FORCE MICROSCOPY; BLOOD BRAIN BARRIER; CELL POLARITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TIGHT JUNCTION; WESTERN BLOTTING;

ALZHEIMER'S DISEASE; AMYLOID-Β; BLOOD-BRAIN BARRIER; CLAUDIN-2; ENDOTHELIAL CELLS; OCCLUDING; PERMEABILITY;

AMYLOID BETA-PEPTIDES; ANIMALS; BLOOD-BRAIN BARRIER; DOGS; EPITHELIAL CELLS; MADIN DARBY CANINE KIDNEY CELLS; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; TIGHT JUNCTIONS;

EID: 84890490409     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122374     Document Type: Article

References (67)

1. Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118, 103-113.
2. Kook SY, Hong HS, Moon M, Ha CM, Chang S, Mook-Jung I (2012) Abeta(1)(-)(4)(2)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca(2)(+)-calcineurin signaling. J Neurosci 32, 8845-8854.
3. Marco S, Skaper SD (2006) Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells. Neurosci Lett 401, 219-224.
4. Nagababu E, Usatyuk PV, Enika D, Natarajan V, Rifkind JM (2009) Vascular endothelial barrier dysfunction mediated by amyloid-beta proteins. J Alzheimers Dis 17, 845-854.
5. Shen L (2012) Tight junctions on the move:Molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci 1258, 9-18.
6. Tai LM, Holloway KA, Male DK, Loughlin AJ, Romero IA (2010) Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med 14, 1101-1112.
7. CasertaMT, Caccioppo D, Lapin GD, Ragin A, GroothuisDR (1998) Blood-brain barrier integrity in Alzheimer's disease patients and elderly control subjects. J Neuropsychiatry Clin Neurosci 10, 78-84.
8. Poduslo JF, Curran GL, Wengenack TM, Malester B, Duff K (2001) Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Neurobiol Dis 8, 555-567.
9. Desai BS, Monahan AJ, Carvey PM, Hendey B (2007) Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: Implications for drug therapy. Cell Transplant 16, 285-299.
10. Carmeliet P, De Strooper B (2012) Alzheimer's disease: A breach in the blood-brain barrier. Nature 485, 451-452.
11. Dorfel MJ, Huber O (2012) Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol 2012, 807356.
12. Romanitan MO, Popescu BO, Winblad B, BajenaruOA, Bogdanovic N (2007) Occludin is overexpressed in Alzheimer's disease and vascular dementia. J Cell Mol Med 11, 569-579.
13. RomanitanMO, Popescu BO, Spulber S, Bajenaru O, Popescu LM, Winblad B, Bogdanovic N (2010) Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains. J Cell Mol Med 14, 1088-1100.
14. Viggars AP, Wharton SB, Simpson JE, Matthews FE, Brayne C, Savva GM, Garwood C, Drew D, Shaw PJ, Ince PG (2011) Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: A study in the MRC-CFASpopulation neuropathology cohort. Neurosci Lett 505, 25-30.
15. Gonzalez-Velasquez FJ, Kotarek JA, Moss MA (2008) Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers. J Neurochem 107, 466-477.
16. Deli MA, Veszelka S, Csiszar B, Toth A, Kittel A, Csete M, Sipos A, Szalai A, Fulop L, Penke B, Abraham CS, Niwa M (2010) Protection of the blood-brain barrier by pentosan against amyloid-beta-induced toxicity. J Alzheimers Dis 22, 777-794.
17. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S (2000) Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11, 4131-4142.
18. Balcells M, Wallins JS, Edelman ER (2008) Amyloid beta toxicity dependent upon endothelial cell state. Neurosci Lett 441, 319-322.
19. Carrano A, Hoozemans JJ, van der Vies SM, van Horssen J, de Vries HE, Rozemuller AJ (2012) Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy. Neurodegener Dis 10, 329-331.
20. Hartz AM, Bauer B, Soldner EL, Wolf A, Boy S, Backhaus R, Mihaljevic I, Bogdahn U, Klunemann HH, Schuierer G, Schlachetzki F (2012) Amyloid-beta contributes to bloodbrain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 43, 514-523.
21. Pop V, Sorensen DW, Kamper JE, Ajao DO, Paul Murphy M, Head E, Hartman RE, Badaut J (2013) Early brain injury alters the blood-brain barrier phenotype in parallel with betaamyloid and cognitive changes in adulthood. J Cereb Blood Flow Metab 33, 205-214.
22. Dukes JD, Whitley P, Chalmers AD (2011) The MDCK variety pack: Choosing the right strain. BMC Cell Biol 12, 43.
23. Scannevin RH, Murakoshi H, Rhodes KJ, Trimmer JS (1996) Identification of a cytoplasmic domain important in the polarized expression and clustering of the Kv2.1 K+ channel. J Cell Biol 135, 1619-1632.
24. Haass C, Koo EH, Capell A, Teplow DB, Selkoe DJ (1995) Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J Cell Biol 128, 537-547.
25. Nazer B, Hong S, Selkoe DJ (2008) LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model. Neurobiol Dis 30, 94-102.
26. Haass C, Koo EH, Teplow DB, Selkoe DJ (1994) Polarized secretion of beta-amyloid precursor protein and amyloid betapeptide in MDCK cells. Proc Natl Acad Sci U S A 91, 1564-1568.
27. Capell A, Meyn L, Fluhrer R, Teplow DB, Walter J, Haass C (2002) Apical sorting of beta-secretase limits amyloid betapeptide production. J Biol Chem 277, 5637-5643.
28. Wang Q, Rager JD, Weinstein K, Kardos PS, Dobson GL, Li J, Hidalgo IJ (2005) Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier. Int J Pharm 288, 349-359.
29. Kobiler D, Lustig S, Shapira S, Abbott NJ, Reichel A, Chishty M, Read K, Taylor J, Begley D (2002) Measurement and prediction of blood-brain barrier permeability. In Blood-Brain Barrier, Springer US, pp. 27-44.
30. Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst RD, Lindmark T, Mabondzo A, Nilsson JE, Raub TJ, Stanimirovic D, Terasaki T, Oberg JO, Osterberg T (2005) In vitro models for the blood-brain barrier. Toxicol In Vitro 19, 299-334.
31. Weiss N, Miller F, Cazaubon S, Couraud PO (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788, 842-857.
32. Sjo A, Magnusson KE, Peterson KH (2003) Distinct effects of protein kinase C on the barrier function at different developmental stages. Biosci Rep 23, 87-102.
33. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyteendothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7, 41-53.
34. Famulski JK, Solecki DJ (2013) New spin on an old transition: Epithelial parallels in neuronal adhesion control. Trends Neurosci 36, 163-173.
35. Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R, Marky A, Lenting PJ, Wu Z, Zarcone T, Goate A, Mayo K, Perlmutter D, Coma M, Zhong Z, Zlokovic BV (2007) Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med 13, 1029-1031.
36. Prozialeck WC, Lamar PC (1998) Comparison of the cytotoxic effects of cadmium (Cd(2+)) in high and low resistance strains of MDCK cells that express different levels of ECadherin. Toxicol In Vitro 12, 633-647.
37. Santaguida S, Janigro D, Hossain M, Oby E, Rapp E, Cucullo L (2006) Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: A permeability study. Brain Res 1109, 1-13.
38. Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, FrommM(2002) Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115, 4969-4976.
39. Buzhynskyy N, Hite RK, Walz T, Scheuring S (2007) The supramolecular architecture of junctional microdomains in native lens membranes. EMBO Rep 8, 51-55.
40. Vedula SR, Lim TS, Kausalya PJ, Hunziker W, Rajagopal G, Lim CT (2005) Biophysical approaches for studying the integrity and function of tight junctions. Mol Cell Biomech 2, 105-123.
41. Han B, Karim MN (2008) Cytotoxicity of aggregated fullerene C60 particles on CHO and MDCK cells. Scanning 30, 213-220.
42. Rabinovich Y, Esayanur M, Daosukho S, Byer K, El-Shall H, Khan S (2005) Atomic force microscopy measurement of the elastic properties of the kidney epithelial cells. J Colloid Interface Sci 285, 125-135.
43. Ludwig T, Oberleithner H (2004) Platinum complex toxicity in cultured renal epithelia. Cell Physiol Biochem 14, 431-440.
44. Poole K, Meder D, Simons K, Muller D (2004) The effect of raft lipid depletion on microvilli formation in MDCK cells, visualized by atomic force microscopy. FEBS Lett 565, 53-58.
45. Lesniewska E, Giocondi MC, Vie V, Finot E, Goudonnet JP, Le Grimellec C (1998) Atomic force microscopy of renal cells: Limits and prospects. Kidney Int Suppl 65, S42-S48.
46. Hoh JH, Schoenenberger CA (1994) Surface morphology and mechanical properties of MDCK monolayers by atomic force microscopy. J Cell Sci 107(Pt 5), 1105-1114.
47. Oberleithner H, Giebisch G, Geibel J (1993) Imaging the lamellipodium of migrating epithelial cells in vivo by atomic force microscopy. Pflugers Arch 425, 506-510.
48. Cedazo-Minguez A, Popescu BO, Blanco-Millan JM, Akterin S, Pei JJ, Winblad B, Cowburn RF (2003) Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta. J Neurochem 87, 1152-1164.
49. Giaever I, Keese CR (1991) Micromotion of mammalian cells measured electrically. Proc Natl Acad Sci U S A 88, 7896-7900.
50. JepsonMA(2003) Disruption of epithelial barrier function by H2O2: Distinct responses of Caco-2 and Madin-Darby canine kidney (MDCK) strains. Cell Mol Biol (Noisy-le-grand) 49, 101-112.
51. Asphahani F, Thein M, Veiseh O, Edmondson D, Kosai R, Veiseh M, Xu J, Zhang M (2008) Influence of cell adhesion and spreading on impedance characteristics of cell-based sensors. Biosens Bioelectron 23, 1307-1313.
52. Ghenim L, Kaji H, Hoshino Y, Ishibashi T, Haguet V, Gidrol X, NishizawaM(2010) Monitoring impedance changes associated with motility and mitosis of a single cell. Lab Chip 10, 2546-2550.
53. Han A, Yang L, Frazier AB (2007) Quantification of the heterogeneity in breast cancer cell lines using whole-cell impedance spectroscopy. Clin Cancer Res 13, 139-143.
54. Hong J, Kandasamy K, Marimuthu M, Choi CS, Kim S (2011) Electrical cell-substrate impedance sensing as a non-invasive tool for cancer cell study. Analyst 136, 237-245.
55. Gaspar S, David S, Polonschii C, Marcu I, Gheorghiu M, Gheorghiu E (2012) Simultaneous impedimetric and amperometric interrogation of renal cells exposed to a calculus-forming salt. Anal Chim Acta 713, 115-120.
56. Benilova I, Karran E, De Strooper B (2012) The toxic Abeta oligomer and Alzheimer's disease: An emperor in need of clothes. Nat Neurosci 15, 349-357.
57. Spulber S, Bogdanovic N, Romanitan MO, Bajenaru OA, Popescu BO (2012) Claudin expression profile separates Alzheimer's disease cases from normal aging and from vascular dementia cases. J Neurol Sci 322, 184-186.
58. Blasig IE, Bellmann C, Cording J, Del Vecchio G, Zwanziger D, Huber O, Haseloff RF (2011) Occludin protein family: Oxidative stress and reducing conditions. Antioxid Redox Signal 15, 1195-1219.
59. Overgaard CE, Daugherty BL, Mitchell LA, Koval M (2011) Claudins: Control of barrier function and regulation in response to oxidant stress. Antioxid Redox Signal 15, 1179-1193.
60. Macdonalds JR (1987) Impedance Spectroscopy: Emphasizing Solid Materials and Systems, Wiley.
61. Wang H, Ma J, Tan Y, Wang Z, Sheng C, Chen S, Ding J (2010) Amyloid-beta1-42 induces reactive oxygen speciesmediated autophagic cell death in U87 and SH-SY5Y cells. J Alzheimers Dis 21, 597-610.
62. Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12, 723-738.
63. Saitou M, Fujimoto K, Doi Y, Itoh M, Fujimoto T, Furuse M, Takano H, Noda T, Tsukita S (1998) Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 141, 397-408.
64. Schulzke JD, Gitter AH, Mankertz J, Spiegel S, Seidler U, Amasheh S, Saitou M, Tsukita S, Fromm M (2005) Epithelial transport and barrier function in occludin-deficient mice. Biochim Biophys Acta 1669, 34-42.
65. Furuse M, Furuse K, Sasaki H, Tsukita S (2001) Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153, 263-272.
66. Popescu BO, Toescu EC, Popescu LM, Bajenaru O, Muresanu DF, SchultzbergM, BogdanovicN(2009) Blood-brain barrier alterations in ageing and dementia. J Neurol Sci 283, 99-106.
67. Gonzalez JE, DiGeronimo RJ, Arthur DE, King JM (2009) Remodeling of the tight junction during recovery from exposure to hydrogen peroxide in kidney epithelial cells. Free Radic Biol Med 47, 1561-1569.